Audentes Therapeutics Stock Forecast

Sell candidate since Jun 11, 2026 Gain 0.72%

The Audentes Therapeutics Inc. stock price fell by -2.10% on the last day (Monday, 22nd Jun 2026) from $1.43 to $1.40. During the last trading day the stock fluctuated 5.00% from a day low at $1.40 to a day high of $1.47. The price has been going up and down for this period, and there has been a -1.41% loss for the last 2 weeks. Volume has increased on the last day by 108 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 170 thousand shares were bought and sold for approximately $238.24 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.31 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 17.11% during the next 3 months and, with a 90% probability hold a price between $1.54 and $2.14 at the end of this 3-month period.

BOLD Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Audentes Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.41 and $1.46. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 16, 2026, and so far it has fallen -14.11%. Further fall is indicated until a new bottom pivot has been found. Audentes Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Audentes Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.18 and $1.13. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Audentes Therapeutics Inc. finds support just below today's level at $1.18. If this is broken, then the next support from accumulated volume will be at $1.13 and $1.08.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.0700 (5.00%) between high and low. For the last week, the stock has had daily average volatility of 3.39%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BOLD) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Audentes Therapeutics Inc. to open at $1.42, and during the day (based on 14 day Average True Range), to move between $1.37 and $1.43, which gives a possible trading interval of +/-$0.0566 (+/-4.12%) up or down from last closing price. If Audentes Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.44 (2.86%) than the support at $1.18 (15.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Audentes Therapeutics Inc. stock A Buy?

The Audentes Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Audentes Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.711 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $1.42 ( 1.67%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk